| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |